MSN/FOX19: Johnson & Johnson COVID-19 vaccine still very effective, UC professor says

UC expert says the important thing is getting as many people vaccinated as possible

Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, was interviewed for a story on the COVID-19 vaccine from by Johnson & Johnson which showed an effective rate of 66%. WXIX-TV/FOX19 produced the story locally which was picked up by MSN nationally. 

Fichtenbaum says it's still worthwhile for people to get the J & J vaccine despite that comparitively low effectiveness rate

a male doctor in a white lab coat gestures with his hands while standing in a laboratory

Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Creative + Brand

With Moderna testing at 94% effective and Pfizer testing at 95%, Fichtenbaum expects that people will have a preference in which vaccine they will receive.

“When we continue to test new vaccines, we’re testing them in a different environment where there are these strains that are emerging where the vaccine may not respond as well,”  Fichtenbaum says. “So, if we tested Moderna or Pfizer vaccine under those conditions, would they still be the same as 95%? I’m not so certain.”

See the entire story here

Lead photo/Getty Images

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.